Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ICP34.5 is a multifunctional neurovirulence factor of herpes simplex virus type 1 (HSV-1). It plays essential roles in viral replication, evasion of host immune responses, and pathogenesis within the nervous system. It counteracts host antiviral responses by recruiting protein phosphatase 1 alpha (PP1α) to dephosphorylate eIF2α, reversing host-induced translational shutoff. It also interacts with Beclin 1 to inhibit autophagy. Loss or mutation in ICP34.5 leads to reduced neurovirulence, impaired replication, increased immune recognition, and attenuated pathogenicity.
Recruits protein phosphatase 1 alpha (PP1α) to dephosphorylate eIF2α, reversing host-induced translational shutoff. Interacts with Beclin 1 to inhibit autophagy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Infected Cell Protein No. 34.5 (ICP34.5).